Busy professionals who cannot commit to multiple daily injections Those prioritising anti-ageing, recovery, and general wellness over peak performance People new to peptide therapy who want a simpler protocol Individuals seeking consistent, week-long GH support for tissue repair Those combining peptide therapy with a broader longevity programme Key Benefits Ultimate Convenience: Only 12 injections per week far more convenient Consistent Support: Steady GH elevation may support better overnight recovery and tissue repair Easier to Manage: Simpler protocol easier to stay compliant Longevity-Focused: Ideal for patients combining with other longevity therapies at Dynasty Clinic Honest Drawbacks Steady GH levels are less natural than pulsatile release If side effects occur (water retention, joint aches), they may persist longer Some experts debate whether continuous GH elevation is optimal long-term CJC-1295 With DAC vs Without DAC: Side-by-Side Comparison How to Choose: A Simple Decision Framework Rather than asking which is better?, ask yourself these questions: Choose CJC-1295 WITHOUT DAC if you Train intensively and want to time GH pulses around workouts Are already comfortable with self-injection protocols Want a more natural, physiological hormone pattern Are stacking with Ipamorelin or another GHRP peptide Prefer rapid clearance for tighter control over hormone levels Choose CJC-1295 WITH DAC if you Have a demanding schedule and can only inject 12x per week Are prioritising anti-ageing, sleep, and recovery over peak muscle gain Are new to peptide therapy and want a simpler starting protocol Are combining with a broader wellness or longevity programme Want consistent, stable GH support throughout the week The bottom line: there is no universally better option
It is not intended for diagnostic, therapeutic, or clinical applications
Role of insulin-like growth factor in cell growth and division Insulin-like growth factor plays a crucial role in cell growth and division, particularly in skeletal muscle cells
Does MK-677 raise blood sugar
Across these trials, tesamorelin at 2 mg subcutaneously once daily produced a statistically significant reduction in visceral adipose tissue and waist circumference over 26 weeks, with 26-week extension phases showing that the visceral-fat improvement was maintained on continued treatment and, importantly, without adverse effects on blood glucose or lipid parameters in those analyses
